Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advil Migraine Liqui-Gels Join Growing Category, Stress Distinctiveness

This article was originally published in The Tan Sheet

Executive Summary

Upcoming marketing efforts accompanying the introduction of Whitehall-Robins' Advil Migraine Liqui-Gels likely will attempt to differentiate the product from its migraine-specific competitors by emphasizing the analgesic's speedy delivery form.
Advertisement

Related Content

Bayer Aspirin Migraine Gets FDA Nod; Midol May Be On Deck
Bayer Aspirin Migraine Gets FDA Nod; Midol May Be On Deck
Bayer Aspirin Migraine Gets FDA Nod; Midol May Be On Deck
Direct-To-OTC Approvals, Line Extensions Replace Switches In 2000
Acetaminophen Migraine Efficacy Could Lead To Tylenol Line Extension
Women's Tylenol Marks McNeil Foray Into Menstrual Pain Category
Migraine Competition Heats Up Between OTC, Rx Companies
McNeil Motrin Migraine Pain, Aflexa Supplement National Ads Breaking Soon
McNeil Motrin Migraine Pain, Aflexa Supplement National Ads Breaking Soon
Excedrin Migraine Full Migraine Indication Approved By FDA

Topics

Advertisement
UsernamePublicRestriction

Register

PS091139

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel